NCT04923516

Prevalence of Acute Hepatic Porphyria

Prevalence of Acute Hepatic Porphyria in Population With Suggestive Clinical Picture

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 150 (actual)
• Sponsor: Association pour la Recherche en Medecine Interne · Network
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

To determine the proportion of patients suffering from acute hepatic porphyria (AHP) from different hospital departments and referred to an internist referent for a suggestive clinical picture with a first negative etiological assessment.

Detailed description

In this context, this study aims to assess the prevalence of PHA in a population of patients with a suggestive clinical picture. A better knowledge of the pathology will make it possible to better guide patients and prevent them from diagnostic wandering fraught with physical and psychological consequences. This is an observational, ambispective, transversal, multicenter study carried out in France. The goal is to recruit a cohort that will reflect current practice. 500 patients will be recruted.

Conditions

• Acute Hepatic Porphyria

Interventions

Type	Name	Description
OTHER	Dosage of Delta-aminolevulinic acid and Porphobilinogen	Results of dosages of Delta-aminolevulinic acid and Porphobilinogen which are performed in accordance with the current practice will be recorded

Timeline

• Start date: 2021-08-23
• Primary completion: 2023-12-29
• Completion: 2023-12-29
• First posted: 2021-06-11
• Last updated: 2026-01-28

Locations

1 site across 1 country: France